Dashboard

Perspective Therapeutics, Inc.

CATXNYSE American

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$299M

Price$2.6252w $2.05 – $5.65

Conviction3/ 5

Revenue (TTM)$409,000

Revenue growth YoY-67.6%

P/E (trailing)—

Gross margin-612.0%

Operating margin-30619.1%

Net margin-28468.0%

52w price change+9.6%

Next earningsNov 9, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Sep 14
OtherSEC
Filed 8-K with items 8.01 and 9.01.
Sep 8
OtherSEC
8-K filing (items 8.01, 9.01) disclosing other events.
Sep 8
Ownership changeSEC
Form 4 filing: statement of changes in beneficial ownership of securities.
Sep 4
Ownership changeSEC
Form 4 filing reporting change in beneficial ownership of securities by insider.
Sep 4
Ownership changeSEC
Form 4 filing: statement of changes in beneficial ownership of securities.
Sep 3
Ownership changeSEC
SEC Form 4 filed reporting change in beneficial ownership of securities.
Sep 2
Ownership changeSEC
Form 4 filing: statement of changes in beneficial ownership of securities.
Aug 10
Financial resultsSEC
8-K filing (items 2.02, 8.01, 9.01) disclosing financial results.
Aug 3
OtherSEC
8-K filing under items 8.01 and 9.01 (other events and exhibits).
Jul 1
OtherSEC
8-K filing with items 8.01 (other events) and 9.01.
Jun 1
OtherSEC
8-K filing (items 8.01, 9.01) on 2026-06-01 disclosing other events.
May 27
OtherSEC
8-K item 5.07 filing on matters submitted to security holder vote.
May 22
OtherSEC
Filed 8-K on 2026-05-22 covering items 8.01 (other events) and 9.01.
May 11
Financial resultsSEC
8-K filing (items 2.02, 8.01, 9.01) reporting financial results.

Not financial advice — research and opinion only. Disclosures